HSD10 disease is characterized by progressive neurodegeneration and includes intellectual disability, language defects, bradykinesia, ataxia, epilepsy, visual and auditory disorders, hypotonia, cardiomyopathy and metabolic disorders. This evidence concerns the gene FSIP1 and cerebellar ataxia.